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Abstract We previously showed that sphingosine 1-phosphate 
(SPP) acts as a second messenger for tumor necrosis factor oc-
induced interleukin-6 (IL-6) synthesis in osteoblast-like MC3T3-
E l cells. In the present study, we further investigated the 
mechanism of IL-6 synthesis induced by S P P in MC3T3-E1 
cells. S P P significantly induced p42/p44 mitogen-activated 
protein (MAP) kinase activity. PD98059, an inhibitor of MAP 
kinase kinase, suppressed SPP-induced IL-6 synthesis as well as 
SPP-induced MAP kinase activation. The patterns of both 
inhibitions were similar. TMB-8, an inhibitor of Ca 2 + mobiliza-
tion from intracellular Ca 2 + stores, significantly suppressed the 
SPP-induced IL-6 synthesis. These results strongly suggest that 
SPP-induced IL-6 synthesis is mediated via p42/p44 MAP 
kinase activation in osteoblast-like cells and that the SPP-
induced IL-6 synthesis is dependent on intracellular Ca 2 + 
mobilization. 
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1. Introduction 
Recently, sphingolipid and its metabolites have been impli-
cated in diverse cellular functions [1,2]. Breakdown of sphin-
gomyelin through sphingomyelinase results in the formation 
of ceramide, which is subsequently metabolized to sphingosine 
and sphingosine 1-phosphate (SPP) [1,2]. Ceramide has been 
reported to induce apoptosis in several cells, whereas sphin-
gosine and SPP are mitogenic. Accumulating evidence indi-
cates that these sphingosine metabolites act as second messen-
gers and mediate several biological effects induced by 
extracellular agonists such as tumor necrosis factor-a (TNF) 
[3-5]. In bone cells, it has been reported that not ceramide but 
sphingosine and SPP induce a transient elevation in intracel-
lular free Ca 2 + from intracellular stores in osteoblast-like 
MC3T3-E1 cells [6]. However, the physiological roles of 
sphingosine derivatives have not yet been clarified. We have 
recently reported that T N F , a potent bone resorptive agent 
[7], induces sphingomyelin turnover in osteoblast-like 
MC3T3-E1 cells and SPP acts as a second messenger for 
TNF-induced IL-6 synthesis [8]. We also showed that T N F 
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autoregulates IL-6 synthesis due to protein kinase C activa-
tion via phosphatidylcholine-specific phospholipase C [8]. 
Mitogen-activated protein (MAP) kinases play important 
roles in intracellular signaling of a variety of agonists [9]. In 
osteoblasts, it has been reported that M A P kinases are acti-
vated by several agonists such as basic fibroblast growth fac-
tor and estrogen [10,11]. In the present study, we investigated 
the potential involvement of M A P kinase in signaling for IL-6 
synthesis induced by SPP in osteoblast-like MC3T3-E1 cells. 
We here show that p42/p44 M A P kinase activation is involved 
in SPP-induced IL-6 synthesis in these cells and that the IL-6 
synthesis is dependent on intracellular Ca 2 + mobilization. 
2. Materials and methods 
2.1. Materials 
Mouse IL-6 enzyme immunoassay kit and p42/p44 MAP kinase 
enzyme assay system were purchased from Amersham Japan (Tokyo, 
Japan). SPP was obtained from Funakoshi Pharmaceutical Co. (To-
kyo, Japan). PD98059 was obtained from Calbiochem (La Jolla, CA, 
USA). 8-(ATJV-Diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) 
was purchased from Research Biochemicals Inc. (Natick, MA, USA). 
Other materials and chemicals were obtained from commercial sour-
ces. PD98059 was dissolved in dimethyl sulfoxide. The maximum 
concentration of dimethyl sulfoxide was 0.1%, which did not affect 
the assay for IL-6 nor the measurement of p42/p44 MAP kinase 
activity. 
2.2. Cell culture 
Cloned osteoblast-like MC3T3-E1 cells derived from newborn 
mouse calvaria [12,13] were maintained as previously described [14]. 
Briefly, the cells were cultured in a-minimum essential medium (oc-
MEM) containing 10% fetal calf serum (FCS) at 37°C in a humidified 
atmosphere of 5% C02/95% air. The cells (5X 10
4) were seeded into 
35-mm diameter dishes in 2 ml of a-MEM containing 10% FCS. After 
5 days, the medium was exchanged for 2 ml of a-MEM containing 
0.3% FCS. The cells were used for experiments after 24 h. 
2.3. Assay for IL-6 
The cultured cells were stimulated with various doses of SPP in 1 ml 
of a-MEM containing 0.3%> FCS for the indicated periods. The con-
ditioned medium was collected, and IL-6 in the medium was measured 
by an IL-6 enzyme immunoassay kit. When indicated, the cells were 
pretreated with PD98059 or TMB-8 for 20 min. 
2.4. Measurement of p42lp44 MAP kinase activity 
The cultured cells were stimulated with SPP in 1 ml of an assay 
buffer [5 mM 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid, pH 
7.4, 150 mM NaCl, 5 mM KC1, 0.8 mM MgS04, 1 mM CaCl2, 5.5 
mM glucose] containing 0.01% bovine serum albumin for the indi-
cated periods. The cells were washed twice with 1 ml of phosphate-
buffered saline and then lysed, homogenized and sonicated in a lysis 
buffer containing 10 mM Tris, 150 mM NaCl, 2 mM EGTA, 2 mM 
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 u.g/ml leupep-
tin, 10 |ig/ml aprotinin and 1 mM sodium orthovanadate. The cyto-
solic fraction was collected as the supernatant after centrifugation at 
125 000 Xg for 10 min at 4°C. MAP kinase activity of the cell extracts 
was then assayed with the use of the p42/p44 MAP kinase enzyme 
assay system. 
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2.5. Determination 
The radioactivity of 32P-labeled samples was determined with a 
Beckman LS-6500IC liquid scintillation spectrometer. 
2.6. Statistical analysis 
The data were analyzed by Student's Z-test and P < 0.05 was con-
sidered significant. All data are presented as the mean ± S.D. of trip-
licate determinations. 
3. Results 
3.1. Effect of SPP on P42IP44 MAP kinase activation in 
MC3T3-E1 cells 
We examined the effect of SPP on p42/p44 M A P kinase 
activation in MC3T3-E1 cells. SPP significantly activated 
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Fig. 1. Effect of SPP on p42/p44 MAP kinase activity in MC3T3-E1 
cells. A: The cultured cells were stimulated with 30 uM SPP (•) or 
vehicle (o) for the indicated periods. B: The cultured cells were 
stimulated with various doses of SPP for 20 min. Each value repre-
sents the mean ± S.D. of triplicate determinations. Similar results 
were obtained with two additional and different cell preparations. 
*P < 0.05, compared to the value of control. 
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Fig. 2. Effect of PD98059 on the SPP-induced activation of p42/p44 
MAP kinase in MC3T3-E1 cells. The cultured cells were pretreated 
with various doses of PD98059 for 20 min, and then stimulated 
with 30 U.M SPP (•) or vehicle (o) for 20 min. Each value repre-
sents the mean ± S.D. of triplicate determinations. Similar results 
were obtained with two additional and different cell preparations. 
*P < 0.05, compared to the value of SPP alone. 
p42/p44 M A P kinase time-dependently up to 30 min (Fig. 
1A). The stimulative effect of SPP on the M A P kinase activa-
tion was dose-dependent in the range between 1 and 30 u M 
(Fig. IB). In addition, we investigated the effect of PD98059, 
an inhibitor of M A P kinase kinase (MEK) [15,16], on the 
SPP-induced activation of p42/p44 M A P kinase. PD98059 
suppressed the p42/p44 M A P kinase activation by SPP dose-
dependently in the range between 0.1 and 30 u M (Fig. 2). 
3.2. Effect of PD98059 on SPP-induced IL-6 synthesis in 
MC3T3-E1 cells 
We previously showed that IL-6 synthesis is stimulated not 
by ceramide or sphingosine but by SPP in osteoblast-like 
MC3T3-E1 cells [8]. In order to investigate whether p42/p44 
M A P kinase is involved in SPP-stimulated IL-6 synthesis, we 
examined the effect of M E K inhibitor on the IL-6 synthesis 
induced by SPP. PD98059 significantly suppressed the SPP-
induced IL-6 synthesis (Fig. 3). The inhibitory effect of 
PD98059 on IL-6 synthesis was dose-dependent in the range 
between 0.1 and 30 u M . 
Table 1 
Effect of TMB-8 on the SPP-induced IL-6 synthesis in MC3T3-E1 
cells 
TMB-8 (30 uM) SPP (30 uM) IL-6 (pg/ml) 
<10 
229 ± 29 
<10 
88± 11* 
The cultured cells were pretreated with 30 uM TMB-8 or vehicle for 
20 min, and then stimulated with 30 U.M SPP or vehicle for 48 h. Each 
value represents the mean ± S.D. of triplicate determinations. Similar 
results were obtained with two additional and different cell prepara-
tions. *P<0.05, compared to the value of SPP alone. 
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Fig. 3. Effect of PD098059 on the SPP-induced synthesis of IL-6 in 
MC3T3-E1 cells. The cultured eels were pretreated with various 
doses of PD98059 for 20 min, and then stimulated with 30 uM SPP 
(•) or vehicle (o) for 48 h. Each value represents the mean±S.D. 
of triplicate determinations. Similar results were obtained with two 
additional and different cell preparations. *P<0.05, compared to 
the value of SPP alone. 
3.3. Effect of TMB-8 on SPP-induced IL-6 synthesis and 
p42lp44 MAP kinase activation in MC3T3-E1 cells 
It has been reported that SPP mobilizes free Ca2+ from 
intracellular stores in osteoblast-like MC3T3-E1 cells [7]. 
Thus, we next examined the effect of TMB-8, an inhibitor 
of Ca2+ mobilization from intracellular stores [17], on the 
SPP-induced IL-6 synthesis. TMB-8, which alone had little 
effect on IL-6 synthesis, inhibited the IL-6 synthesis stimu-
lated by SPP (Table 1). In contrast, the SPP-induced p42/ 
p44 MAP kinase activation was not affected by TMB-8 
(SPP alone, 32.2 ±3.0 pmol/min; SPP with 30 uM TMB-8, 
31.1 ±2.9 pmol/min, as measured during 20 min stimulation 
after 20 min pretreatment of TMB-8 or vehicle). 
4. Discussion 
In our previous report [8], we demonstrated that TNF in-
duces sphingomyelin hydrolysis in osteoblast-like MC3T3-E1 
cells, and that SPP acts as an intracellular second messenger 
in TNF-induced IL-6 synthesis. In the present study, we fur-
ther investigated the exact mechanism underlying SPP-stimu-
lated IL-6 synthesis in these cells. We showed that SPP mark-
edly stimulated p42/p44 MAP kinase in MC3T3-E1 cells and 
that an MEK inhibitor suppressed SPP-induced synthesis of 
IL-6 as well as SPP-activated p42/p44 MAP kinase. The dose 
response for the inhibition of IL-6 synthesis by the MEK 
inhibitor closely correlated with the concentration required 
for the p42/p44 MAP kinase activation. Therefore, these find-
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ings suggest that p42/p44 MAP kinase activation is involved 
in the SPP-induced IL-6 synthesis in osteoblast-like MC3T3-
El cells. 
We next demonstrated that TMB-8 suppressed the SPP-in-
duced IL-6 synthesis without affecting p42/p44 MAP kinase 
activation induced by SPP. It has been reported that SPP 
induces Ca2+ mobilization from intracellular stores in several 
cells [18,19]. In osteoblast-like MC3T3-E1 cells [7], SPP has 
been shown to mobilize Ca2+ from intracellular stores. Taking 
these findings into account, it is most likely that intracellular 
Ca2+ mobilization by SPP has an important role at a point 
downstream from p42/p44 MAP kinase in the SPP-induced 
IL-6 synthesis in osteoblast-like MC3T3-E1 cells. 
In conclusion, these results strongly suggest that in IL-6 
synthesis, p42/p44 MAP kinase may act at a point down-
stream from SPP in osteoblast-like cells and that the SPP-
induced IL-6 synthesis is dependent on intracellular Ca2+ mo-
bilization. 
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